ZYDUSLIFE — Zydus Lifesciences Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Zydus Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	R2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	22,848	28,381	25,897	48,089	60,267
Depreciation
Non-Cash Items	5,070	-1,627	5,163	-999	2,425
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-3,315	-13,333	-11,399	-22,392	-3,917
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	31,851	20,782	26,888	32,339	67,933
Capital Expenditures	-8,540	-12,026	-10,309	-9,066	-17,126
Purchase of Fixed Assets
Other Investing Cash Flow Items	1,315	23,570	25,659	-5,686	-66,597
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-7,225	11,544	15,350	-14,752	-83,723
Financing Cash Flow Items	-3,233	-1,111	-1,262	-729	-895
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-25,489	-8,683	-44,004	-18,104	20,142
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-905	23,729	-1,700	-748	4,138